| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 22.242 | 47.150 | 59.806 | 77.387 |
| Total Income - EUR | - | - | - | - | - | - | 22.242 | 47.452 | 60.541 | 77.388 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.017 | 6.558 | 17.408 | 18.684 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 20.225 | 40.894 | 43.133 | 58.704 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 19.668 | 39.875 | 42.715 | 56.428 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Gynaecomed Diagnostic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 19.921 | 40.272 | 52.721 | 57.854 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 1.708 | 28.638 | 210 | 42.375 |
| Cash | - | - | - | - | - | - | 18.213 | 11.633 | 52.511 | 15.479 |
| Shareholders Funds | - | - | - | - | - | - | 19.708 | 39.924 | 51.588 | 56.477 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 212 | 348 | 1.133 | 1.377 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynaecomed Diagnostic S.r.l.